L740-0688 Screening compound: N~1~-(4-bromophenyl)-3-oxo-4-{2-oxo-2-[(2-pyridylmethyl)amino]ethyl}tetrahydro-1(2H)-pyrazinecarboxamide

L740-0688 Screening compound: N~1~-(4-bromophenyl)-3-oxo-4-{2-oxo-2-[(2-pyridylmethyl)amino]ethyl}tetrahydro-1(2H)-pyrazinecarboxamide
L740-0688 Screening compound: N~1~-(4-bromophenyl)-3-oxo-4-{2-oxo-2-[(2-pyridylmethyl)amino]ethyl}tetrahydro-1(2H)-pyrazinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L740-0688
N~1~-(4-bromophenyl)-3-oxo-4-{2-oxo-2-[(2-pyridylmethyl)amino]ethyl}tetrahydro-1(2H)-pyrazinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L740-0688

Molecular Formula

C19H20BrN5O3 (C19 H20 BrN5 O3)

Compound Name

N~1~-(4-bromophenyl)-3-oxo-4-{2-oxo-2-[(2-pyridylmethyl)amino]ethyl}tetrahydro-1(2H)-pyrazinecarboxamide

IUPAC name

n/a

SMILES

O=C(CN(CCN(C1)C(Nc(cc2)ccc2Br)=O)C1=O)NCc1ncccc1

InChI

InChI=1S/C19H20BrN5O3/c20-14-4-6-15(7-5-14)23-19(28)25-10-9-24(18(27)13-25)12-17(26)22-11-16-3-1-2-8-21-16/h1-8H,9-13H2,(H,22,26)(H,23,28)

InChI Key

UXDXQSIQCGWAKT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27473420

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

446.3

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.447

Distribution Coefficient, logD

1.446

Water Solubility, LogSw

-2.09

Polar Surface Area

76.360

Acid Dissociation Constant (pKa)

12.24

Base Dissociation Constant (pKb)

4.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.30

L740-0688 in Drug Discovery

Included in Screening Libraries

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Immune system
Targets:
  • Proteases
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L740-0688 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L740-0688?
Check Price and Availability of L740-0688, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L740-0688 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L740-0688
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L740-0688
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L740-0688 available by request